Articles

Videos

Podcasts

The forthcoming strategic plan will be focused on guiding future NIH research efforts to improve the health of all women throughout the life course.

NIH Requests Input from Pharmacists on Wide Strategic Plan for Research on Women’s Health 

For patients suffering from a higher left ventricular ejection fraction, a sodium-glucose cotransporter 2 inhibitor could decrease risk of hospitalization or death from heart failure.

Dapagliflozen May Decrease Fatal Risks of Heart Failure Associated With Higher Ejection Fraction

Pharmacists play an important role in the recovery journey for patients who decide medication assisted treatment is right for them. 

Expert: Alcohol Dependence Is an Epidemic, Yet Treatments Exist

Combination treatment with ibrutinib found to increase median progression-free survival by 2.3 years compared to the placebo.  

Ibrutinib Combined with Standard Chemoimmunotherapy Found to Increase Progression-Free Survival in Mantle Cell Lymphoma

There were approximately 250,000 new cases of prostate cancer identified in the United States in 2021, which is considered approximately 13% of all cancer cases.

Clinical Overview: Treatment Options for Prostate Cancer

We spoke with Brandon Dyson, PharmD, BCOP, co-founder of TL;DR Pharmacy, to hear about this unique resource for pharmacy students.

Pharmacy Focus: Student Edition - Communication Skills for Pharmacy Students

On this week's episode, host Joanna speaks with Charlie Conway, PhD, chief scientific officer at Biohaven Pharmaceuticals about migraine function, care, and treatment.

Pharmacy Focus: On The Shelf - All About Migraine

Study finds that 13% of all heart-related emergency department visits were related to essential hypertension.

Study: Many Cardiovascular Emergencies Related to Poorly Controlled High Blood Pressure 

Investigators combine research discovery with technological development to determine whether the role of genomics in nephrology should remain with subspecialists or be integrated into general nephrology.

Genomic Testing Framework for Chronic Kidney Disease Continues to Grow

Gadopiclenol is a macrocyclic gadolinium-based contrast indicated for use in adults and children 2 years of age and older for contrast-enhanced MRI.

All News